About Pharma Focus Asia
Pharma Focus Asia is a Healthcare company based in Hyderabad (India). Pharmaceutical magazine providing insights, articles, and industry updates. It operates in the Healthcare and Media & Entertainment sectors. Its Indian entity Ochre Digi Media Private Limited reported revenue of ₹2.66 Cr. Pharma Focus Asia offers products and services including Pharma Magazine and Webinars and Events. Its focus areas include Pharmaceuticals, Industry Updates, Research and Development Coverage and Media and Publishing.
Company details
Pharma Focus Asia is recognized as a leading platform where industry insights and updates are delivered through articles, interviews, and case studies on topics like clinical trials, AI in drug development, and supply chain innovations. The magazines knowledge bank and editorial sections are utilized to cover research, manufacturing, and events, ensuring that pharmaceutical advancements are explored in detail. Subscriptions and advertising opportunities are offered to engage stakeholders, while events such as BIO Asia-Taiwan are highlighted to foster global collaboration in the sector. Overall, it serves as a resource where information is shared to support professional growth in pharmaceuticals.
- Headquarters Hyderabad, India
- SectorsHealthcareMedia & Entertainment
- Phone•••• ••••
- Website pharmafocusasia.com
- Social LinkedIn X Facebook
- Legal Name Ochre Digi Media Pvt Ltd
- Date of Incorporation 21 Apr, 2023
- Jurisdiction Secunderabad, Telangana, India
- Annual Revenue₹2.66 Cr
FY 2024
- Net Profit₹1.17 Cr
FY 2024 · 44% margin
- EBITDA₹1.59 Cr
FY 2024 · 60% margin
Associated legal entities of Pharma Focus Asia
Pharma Focus Asia operates through Ochre Digi Media Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ochre Digi Media Private Limited CIN U62099TS2023PTC172216 | Active | 21 Apr 2023 | Secunderabad, Telangana | ₹2.7 Cr | 22 | 2 | View details |
Products & Services of Pharma Focus Asia
Pharma Focus Asia offers a comprehensive portfolio of products and services, including Pharma Magazine and Webinars and Events.
Industry insights and articles are delivered through the magazine to cover pharmaceutical topics
Webinars and event listings are provided to facilitate knowledge sharing in the pharmaceutical sector
Board of directors of Ochre Digi Media Private Limited (Pharma Focus Asia)
Ochre Digi Media Private Limited is the primary company behind Pharma Focus Asia. The board of Ochre Digi Media Private Limited currently have 2 directors; the longest-serving is Venkata Nageswara Rao Sivala, appointed in 2023.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkata Nageswara Rao Sivala DIN 05296495 | Director | 21 Apr 2023 | 3 yrs 6 mo | Ochre Digi Media Private Limited |
| Bhavani Prasad DIN 10127701 | Director | 21 Apr 2023 | 3 yrs 6 mo | Ochre Digi Media Private Limited |
Financials of Pharma Focus Asia
Figures of Ochre Digi Media Private Limited, the primary company behind Pharma Focus Asia, for FY 2024. Revenue was ₹2.66 Cr. Net profit was ₹1.17 Cr (44% margin). EBITDA was ₹1.59 Cr (60% margin).
- ₹2.66 CrRevenue · FY 2024
- ₹1.17 CrNet profit · 44% margin
- ₹1.59 CrEBITDA · 60% margin
- ₹1 LakhPaid-up capital
- 22Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Ochre Digi Media Private Limited are on its company page.
Detailed financial statements for Pharma Focus Asia
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Pharma Focus Asia
Websites that share an audience with Pharma Focus Asia (pharmafocusasia.com).
Websites whose visitors overlap most with Pharma Focus Asia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| servier.com | 74% | 306.8K | #150,173 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pharma Focus Asia
Pharma Focus Asia is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Pharma Focus Asia, Ochre Digi Media Private Limited, reported revenue of ₹2.66 Cr for FY 2024.
Pharma Focus Asia is recognized as a leading platform where industry insights and updates are delivered through articles, interviews, and case studies on topics like clinical trials, AI in drug development, and supply chain innovations. The magazines knowledge bank and editorial sections are utilized to cover research, manufacturing, and events, ensuring that pharmaceutical advancements are explored in detail. Subscriptions and advertising opportunities are offered to engage stakeholders, while events such as BIO Asia-Taiwan are highlighted to foster global collaboration in the sector. Overall, it serves as a resource where information is shared to support professional growth in pharmaceuticals.
Pharma Focus Asia offers Pharma Magazine and Webinars and Events.
Pharma Focus Asia operates through Ochre Digi Media Private Limited.
The legal entities of Pharma Focus Asia currently have 2 directors, including Venkata Nageswara Rao Sivala, Bhavani Prasad.